Search Results for "Butal Acet Caff 50 325 40mg"

22:25 EDT 4th August 2015 | BioPortfolio

Matching Channels


Matching News

Pfizer teams with Synthon on generic Copaxone

Synthon has filed an application for a generic version of Teva's improved 40mg/mL dosage of the multiple sclerosis drug.

Frusol administration update

Frusol (furosemide; Rosemont Pharmaceuticals) oral solutions 20mg/5ml, 40mg/5ml and 50mg/5ml have been approved for administration via nasogastric (NG) or percutaneous endoscopic gastrostomy (PEG) tub...

FDA approves Cipla’s Lopinavir/ritonavir for AIDS in infants and young children

Cipla, a global pharmaceutical company, has received FDA approval for Lopinavir/ritonavir (LPV/r) 40mg/10mg oral pellets for paediatric specific treatment for infants.

Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of Multiple Sclerosis

Synthon’s glatiramer acetate, a potential generic version of Copaxone®1 for the treatment of relapsing remitting multiple sclerosis is currently being reviewed by the U....

Second-Generation Investigational HIV-1 Maturation Inhibitor Demonstrates Positive New Phase IIa Results, Supporting Continued Development

Investigational agent BMS-955176 represents a novel approach since it is designed to inhibit HIV-1 replication as compared to currently available treatments Bristol-Mye...

Osteo Bi-Flex® Introduces EASE Mini-Tabs: Collagen-Based Formula For Every Day Joint Comfort

NEW YORK, May 20, 2015 /PRNewswire/ -- Joint health supplement market leader Osteo Bi-Flex® today introduced Osteo Bi-Flex® EASE, a daily mini-tab that promotes joint comfort through a ...

Neurocrine Biosciences Reports Second Quarter 2015 Results

SAN DIEGO, July 29, 2015 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ:NBIX) today announced its financial results for the quarter ended June 30, 2015. For the second quarter of 2015, the Compa...

DelMar Pharmaceuticals Presents Updated Clinical Data on Phase I/II Study of VAL-083 in Refractory Glioblastoma Multiforme (GBM)

VANCOUVER, British Columbia and MENLO PARK, Calif., April 20, 2015 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (DelMar and the Company), a biopharmaceutical company focused on deve...

Matching PubMed Articles

Coffee and caffeine potentiate the antiamyloidogenic activity of melatonin via inhibition of Aβ oligomerization and modulation of the Tau-mediated pathway in N2a/APP cells.

There is an increasing prevalence of Alzheimer's disease (AD), which has become a public health issue. However, the underlying mechanisms for the pathogenesis of AD are not fully understood, and the c...

Numerical simulation on the opto-electro-kinetic patterning for rapid concentration of particles in a microchannel.

This paper presents a mathematical model for laser-induced rapid electro-kinetic patterning (REP) to elucidate the mechanism for concentrating particles in a microchannel non-destructively and non-inv...

Crystal structure of 1-(2-chloro-acet-yl)-3,3-dimethyl-2,6-di-p-tolyl-piperidin-4-one.

In the title compound, C23H26ClNO2, the piperidin-4-one ring adopts a distorted boat conformation. The two p-tolyl rings are nearly normal to each other, making a dihedral angle of 83.33 (10)°. The...

Carbohydrate mouth rinse and caffeine improves high-intensity interval running capacity when carbohydrate restricted.

We tested the hypothesis that carbohydrate mouth rinsing, alone or in combination with caffeine, augments high-intensity interval (HIT) running capacity undertaken in a carbohydrate-restricted state. ...

Crystal structure of (3S)-3-acet-oxy-17-(pyridin-3-yl)androsta-5,16-diene.

In the title compound, C26H33NO2 [systematic name: (3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodeca-hydro-1H-cyclo-penta-[a]phenanthren-3-yl acetate], the s...

Search Whole site using Google


Advertisement Advertisement